MS4A14 inhibitors refer to chemical compounds that specifically interact with and inhibit the function of the MS4A14 protein, a member of the membrane-spanning 4A (MS4A) family of proteins. The MS4A family consists of several proteins that share structural similarities, characterized by four transmembrane domains, which enable them to be embedded in cellular membranes. MS4A proteins are believed to play a role in signal transduction, although the exact biological functions of many MS4A members, including MS4A14, are still being elucidated. MS4A14 itself is a lesser-known member of this family, and the identification of compounds that act as inhibitors is a growing field of interest, aimed at understanding the protein's functional role in various biochemical pathways. These inhibitors are typically developed through high-throughput screening of chemical libraries, followed by structure-activity relationship (SAR) studies to optimize their interaction with the MS4A14 protein and improve their inhibitory efficacy.
The design of MS4A14 inhibitors generally involves targeting the protein's active sites or regulatory domains to disrupt its natural interactions within the cellular membrane. Researchers focus on elucidating the structural properties of MS4A14, including its transmembrane topology and potential binding pockets, to guide the rational design of these inhibitors. Advanced techniques, such as X-ray crystallography and cryo-electron microscopy, may be employed to map the three-dimensional structure of MS4A14, providing detailed insight into how small molecules interact with the protein. Understanding the inhibitory mechanism of these compounds contributes to broader research efforts aimed at deciphering the molecular function of MS4A proteins, with MS4A14 being a key target in investigations related to its role in cellular signaling pathways and membrane biology. These insights are critical for expanding the knowledge of MS4A family proteins and their biochemical roles in normal and abnormal cellular processes.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $150.00 $388.00 | 113 | |
A kinase inhibitor that can modulate signaling pathways potentially affecting MS4A14 activity. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $30.00 $52.00 $122.00 $367.00 | 25 | |
Disrupts protein transport, possibly affecting MS4A14 localization and function. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $62.00 $90.00 $299.00 $475.00 $1015.00 $2099.00 | 69 | |
Inhibits calcineurin, thereby potentially altering signaling pathways linked to MS4A14. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
Inhibits PI3K, which can impact signaling cascades that MS4A14 might be involved in. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
Inhibits MEK, which could affect MS4A14 through modulation of the MAPK pathway. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $94.00 $349.00 | 114 | |
Disrupts calcium homeostasis, which may have an impact on MS4A14 activity. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Inhibits mTOR, potentially affecting downstream processes involved with MS4A14. | ||||||
W-7 | 61714-27-0 | sc-201501 sc-201501A sc-201501B | 50 mg 100 mg 1 g | $163.00 $300.00 $1642.00 | 18 | |
Inhibits calmodulin, which can alter signaling pathways indirectly associated with MS4A14. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
Inhibits p38 MAPK, potentially influencing signaling pathways related to MS4A14. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Inhibits PI3K, affecting various signaling pathways that could indirectly modulate MS4A14. | ||||||